WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES SAFE-T GROUP LTD.Warrant to Purchase Ordinary Shares • August 10th, 2018 • Safe-T Group Ltd. • Services-prepackaged software • New York
THIS WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after ______________ (the “Initial Exercise Date”) and, in accordance with FINRA Rule 5110(f)(2)(G)(i), will expire at 5:00 PM New York City time on the five (5) year anniversary of the effective date of the registration statement pursuant to which this Warrant is issued (the “Termination Date”), to subscribe for and purchase from Safe-T Group Ltd., a company organized under the laws of the State of Israel (the “Company”), up to ______ Ordinary Shares, no par value (the “Ordinary Share(s)”) (as subject to adjustment hereunder, the “Warrant Shares”)), represented by _____ American Depositary Shares (“ADSs”), as subject to adjustment hereunder, and the ADSs issuable upon exercise of
WARRANT TO PURCHASE ORDINARY SHARES BRENMILLER ENERGY LTD.Warrant to Purchase Ordinary Shares • January 25th, 2024 • Brenmiller Energy Ltd. • Heating equipment, except electric & warm air furnaces
THIS WARRANT TO PURCHASE ORDINARY SHARES (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on [____], 20291 (the “Termination Date”), but not thereafter, to subscribe for and purchase from Brenmiller Energy Ltd., an Israeli corporation (the “Company”), up to ______ ordinary shares, no par value per share (the “Ordinary Shares”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES CAN-FITE BIOPHARMA LTD.Warrant to Purchase Ordinary Shares • February 12th, 2020 • Can-Fite BioPharma Ltd. • Pharmaceutical preparations • New York
THIS WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on February 12, 2025 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Can-Fite BioPharma Ltd., an Israeli limited company (the “Company”), up to ______ Ordinary Shares (the “Warrant Shares”) represented by ________1 American Depositary Shares (“ADSs”), as subject to adjustment hereunder (the “Warrant ADSs”). The purchase price of one Warrant ADS shall be equal to the Exercise Price, as defined in Section 2(b).
AMENDMENT NO. 1 TO WARRANT TO PURCHASE ORDINARY SHARESWarrant to Purchase Ordinary Shares • July 3rd, 2023 • ASLAN Pharmaceuticals LTD • Pharmaceutical preparations • New York
THIS AMENDMENT NO. 1 TO WARRANT TO PURCHASE ORDINARY SHARES is made this 30th day of June, 2023, by and between K2 HealthVentures Equity Trust LLC (“Holder”) and ASLAN Pharmaceuticals Limited, a Cayman Islands exempted company with registration number 289175 (the “Company”).
AMENDMENT NO. 1 TO Warrant to purchase ordinary shares represented by american depositary sharesWarrant to Purchase Ordinary Shares • February 28th, 2023 • Quoin Pharmaceuticals, Ltd. • Surgical & medical instruments & apparatus
This AMENDMENT NO. 1 TO WARRANT TO PURCHASE ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES (this “Amendment”) is entered into as of February 24, 2023, by and between Quoin Pharmaceuticals Ltd., a corporation incorporated under the laws of Israel (the “Company”), and [●] (the “Holder”).
WARRANT TO PURCHASE ORDINARY SHARES GALAXY DIGITAL HOLDINGS LTD.Warrant to Purchase Ordinary Shares • January 28th, 2022 • Galaxy Digital Holdings Ltd. • Security brokers, dealers & flotation companies • New York
This WARRANT TO PURCHASE ORDINARY SHARES (this “Warrant Certificate”), certifies that, for value received and subject to the terms and conditions set forth herein, including, for the avoidance of doubt, Section 6, [●] (the “Holder”), or its permitted assigns, is entitled at any time from and following the date hereof and prior to the Expiry Time, to purchase, acquire, accept and receive up to [●] Ordinary Shares (as adjusted from time to time pursuant to Section 6, the “Warrant Shares”), validly issued, fully paid and non-assessable and free and clear of all Liens, at the Exercise Price. This Warrant Certificate is issued pursuant to the terms and conditions of the Investment Agreement, dated as of October 30, 2020 (the “Investment Agreement”), entered into by and between the Company and the other parties thereto.
